Cargando…
A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients
Prognostic and predictive markers are needed to predict the clinical outcomes of patients with advanced colorectal cancer (CRC) who receive standard first-line treatments. We performed a prospective cohort study in advanced CRC patients to identify a miRNA signature that could predict the benefit of...
Autores principales: | Lu, Jia-huan, Zuo, Zhi-xiang, Wang, Wei, Zhao, Qi, Qiu, Miao-zhen, Luo, Hui-yan, Chen, Zhan-hong, Mo, Hai-yu, Wang, Feng, Yang, Dong-dong, Wang, Yun, Wei, Xiao-li, Wu, Qi-nian, Ju, Huai-qiang, Xu, Rui-hua, Zeng, Zhao-lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299080/ https://www.ncbi.nlm.nih.gov/pubmed/30588338 http://dx.doi.org/10.1038/s41420-018-0133-7 |
Ejemplares similares
-
Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis
por: Bai, Long, et al.
Publicado: (2016) -
Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients
por: Ji, Dengbo, et al.
Publicado: (2018) -
Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer
por: Yang, Yongmei, et al.
Publicado: (2020) -
A panel of microRNA signature in serum for colorectal cancer diagnosis
por: Zhu, Mingxia, et al.
Publicado: (2017) -
Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection
por: Wang, Jia, et al.
Publicado: (2014)